While cell culture studies have provided important insight into the mechanistic basis of Vpu-mediated BST2 antagonism and HIV-1 release, it is not clear how Vpu mutations that impair β-TrCP recruitment and inhibit Vpu-mediated BST2 degradation affect HIV-1 infection in vivo. The gene discussed is BTRC; the disease is HIV-1 infection.